Benchmark Holdings plc (BMK) Ordinary Shares

Sell:21.20pBuy:22.00p0.20p (0.91%)

Prices delayed by at least 15 minutes
Sell:21.20p
Buy:22.00p
Change:0.20p (0.91%)
Prices delayed by at least 15 minutes
Sell:21.20p
Buy:22.00p
Change:0.20p (0.91%)
Prices delayed by at least 15 minutes

Company Information

About this company

Benchmark Holdings plc is a United Kingdom-based aquaculture biotechnology company. The Company delivers products and solutions that enable aquaculture producers to improve their productivity and sustainability. Its segments include Advanced Nutrition and Health. The Advanced Nutrition segment manufactures and provides technically advanced nutrition and health products to the global aquaculture industry. The Health segment is focused on providing health products to the global aquaculture market. Its animal health solutions include Sea Lice Treatments and Water Purification. Sea lice treatments include Ectosan Vet, Salmosan Vet, and Purisan. It also provides early-stage nutrition for shrimp and marine fish, under the brand INVE Aquaculture. The Company’s advanced nutrition products include A1 DHA SELCO, Artemia AF / BF, ARTEMIA EG / TQ, EASY DRY SELCO, S.PRESSO, ARTEMIA HIGH 5, and others.

Key people

Nathan Lane
Chairman of the Board
Trond Williksen
Chief Executive Officer, Executive Director
Septima Maguire
Chief Financial Officer, Executive Director
Corina Holmes
Group Head of People
Ivonne Maria Gloria Cantu
Head of Investor Relations & Corporate Development
Ross Houston
Director - Genetics & Innovation
Geir Olav Melingen
Head - Salmon, Health & Genetics
Patrick Waty
Head of Advanced Nutrition
Jennifer Haddouk
Company Secretary, Group Legal Counsel
Kristian Eikre
Non-Executive Director
Jonathan Esfandi
Non-Executive Director
Torgeir Johan Svae
Non-Executive Director
Marie Danielsson
Non-Executive Independent Director
Yngve Myhre
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    BMK
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    GB00BGHPT808
  • Market cap
    £161.65m
  • Employees
    557
  • Shares in issue
    741.51m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.